DS
DMAQR

David Shaw’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

David Shaw’s Portfolio DMAQR Stock Details DMAQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-296,800
Closed -$89K – 4905
2023
Q4 		$89K Hold
296,800
– – ﹤0.01% 3986
2023
Q3 		$89K Hold
296,800
– – ﹤0.01% 3869
2023
Q2 		$47.5K Hold
296,800
– – ﹤0.01% 3884
2023
Q1 		$41.6K Hold
296,800
– – ﹤0.01% 4058
2022
Q4 		$14.8K Hold
296,800
– – ﹤0.01% 4563
2022
Q3 		$11K Hold
296,800
– – ﹤0.01% 4924
2022
Q2 		$33K Hold
296,800
– – ﹤0.01% 4913
2022
Q1 		$53K Sell
296,800
-183,200
-38% -$46.3K ﹤0.01% 5134
2021
Q4 		$154K Buy
+480,000
New +$152K ﹤0.01% 4958

David Shaw's DMAQR Position: Q1 2024 in Review

David Shaw sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 296,800 shares — an estimated $89K sold.

David Shaw first reported a position in DMAQR in Q4 2021 and held it in 9 quarters. The position peaked at $154K in Q4 2021. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

  • David Shaw reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
  • David Shaw sold 296,800 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $89K.
  • David Shaw first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 9 quarters.
  • David Shaw's Deep Medicine Acquisition Corp. Rights position peaked at $154K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.